INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 41,042 Value ($000) $164 Avg Close — Range —
Q1 2025
Shares 52,978 Value ($000) $48 Avg Close — Range —
Q4 2024
Shares 36,175 Value ($000) $100 Avg Close — Range —
Q3 2024
Shares 25,764 Value ($000) $135 Avg Close — Range —
Q2 2024
Shares 15,773 Value ($000) $70 Avg Close — Range —
Q1 2024
Shares 47,960 Value ($000) $367 Avg Close — Range —
Q4 2023
Shares 46,207 Value ($000) $197 Avg Close — Range —
Q3 2023
Shares 18,917 Value ($000) $79 Avg Close — Range —
Q2 2023
Shares 21,577 Value ($000) $120 Avg Close — Range —
Q4 2022
Shares 2,834 Value ($000) $3 Avg Close — Range —
Q2 2022
Shares 115 Value ($000) $1 Avg Close — Range —
Q1 2022
Shares 6,313 Value ($000) $26 Avg Close — Range —
Q4 2021
Shares 7,228 Value ($000) $49 Avg Close — Range —
Q2 2021
Shares 48 Value ($000) $1 Avg Close — Range —
Q1 2021
Shares 1,002 Value ($000) $20 Avg Close — Range —
Q3 2020
Shares 536 Value ($000) $14 Avg Close — Range —